B型血可能降低消化性溃疡所致上消化道出血患者的再出血风险
该研究评估血型状态对699例消化性溃疡出血患者再出血及并发症的影响,发现B型血与复合结局(再出血、需手术或栓塞及死亡)风险降低相关(OR 0.15,95%CI 0.04-0.63,p=0.009),且B型血较非B型血对再出血有保护作用(OR 0.20,95%CI 0.05-0.84,p=0.028)。
要点
- B型血与消化性溃疡出血患者复合结局风险降低相关(OR 0.15,95%CI 0.04-0.63,p=0.009)。
- B型血较非B型血对再出血有保护作用(OR 0.20,95%CI 0.05-0.84,p=0.028)。
- 血型状态可能有助于消化性溃疡出血的风险分层。
核心结论
- B型血可能降低消化性溃疡出血患者再出血、需手术或栓塞及死亡的复合结局风险,并对再出血有保护作用。
研究设计与样本
- 研究纳入699例消化性溃疡出血患者,评估血型状态对再出血及其他并发症的影响。
主要发现
- B型血与复合结局(再出血、需手术或栓塞及死亡)风险降低相关(OR 0.15,95%CI 0.04-0.63,p=0.009)。
- B型血较非B型血对再出血有保护作用(OR 0.20,95%CI 0.05-0.84,p=0.028)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Risk stratification tools for the prediction of complications in patients with upper gastrointestinal haemorrhage are crucial for appropriate management. Blood group status has been associated with the risk of bleeding, thrombosis and risk of peptic ulcer disease (PUD). We assessed the influence of blood group status on rebleeding and other complications in 699 patients with PUD bleeding. Blood group B was associated with reduced risk in the composite outcome of rebleeding, need for surgery or embolisation and mortality (OR 0.15, 95% CI 0.04-0.63, p = 0.009). Blood group B was protective against rebleeding compared to non-blood group B (OR 0.20, 95% CI 0.05-0.84, p = 0.028).
引用
- Taylor S, Chen L, Dutt K, et al. Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease. Aliment Pharmacol Ther. 2025. PMID: 39789778. doi:10.1111/apt.18485
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。